Kliman: Ophthalmology Is A “Leading Franchise” At InterWest

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 006″] OIS Co-Chair, Gil Kliman, MD, Managing Director at InterWest Partners, delivers insight on his firm’s decision to concentrate on ophthalmology fifteen years ago and shares the many lessons he’s learned during that time. Podcast Guest Gilbert H. Kliman, MD Dr. Gil Kliman leads the medical device investment team at InterWest…

Read More

EU Commercialization Strategies

Summit Co-Chair and Managing Director for InterWest Partners, Gilbert Kliman MD, captures the audience’s thoughts on commercialization strategies in Europe through a series of live polling questions. Also gaining the expert opinions of panelists, Laurent Attias, David Muller, David E.I. Pyott, Jim Mazzo and Andy Corley, Gil compares the who, what and where questions that…

Read More

Bill Link Dives into his Perspective of Venture Overseas

William J. Link PhD, Managing Director for Versant Ventures, gives the audience at the 5th Annual Ophthalmology Innovation Summit a look into the returns on the venture investing side and the comparison between the US and Europe. Utilizing specific data and numbers, Bill continues to share his personal biases as an American in the US…

Read More

Jonathan Norris Predicts a Positive Cycle in the Ophthalmic Private Market

Private Funding and Exit Trends Jonathan Norris, Managing Director for SVB Capital, takes the stage to share the positive sentiments on the private markets. Highlighting in detail venture healthcare funds, Series A and M&A, Jonathan predicts stability in fundraising dollars, while investment dollars in the companies will begin to decline, expanding on the important role…

Read More

Physician Entrepreneurship in Ophthalmology

Striving to reach the aspiring entrepreneurs in the crowd at the 5th Annual Ophthalmology Innovation Summit @ AAO in New Orleans, Dick Lindstrom leads an experienced panel of entrepreneurs and tech developers through a series of focused questions. Sharing their highly coveted successes and failures, these panelists cover all aspects of entrepreneurship from focusing in…

Read More

Alternative Financing Strategies

Charles Warden, Managing Director for Versant Ventures, initiates this finance focused panel by detailing the funding gap that has been referred to often at the 5th Annual Ophthalmology Innovation Summit @ AAO. Gaining insights from Luke Duster of Capital Royalty, Gregory Shearer of Healthios Capital Markets, Brian Demmert of Armentum Partners and Buzz Benson of…

Read More

The Ophthalmology Market – “A View from the Public Sector”

Jeffrey Hoffman, Managing Director and Head of West Coast Healthcare Investment Banking for JPMorgan, gladly addresses the audience at the 5th Annual Ophthalmology Innovation Summit with a promising outlook. Expanding on the rise of individual company risks, Jeffrey shares specific increases in the biotech and life sciences markets, as they recover from a 10-year lull.…

Read More

Going Public – Who, When, and Why?

Detailing the grueling process and levels of determination necessary to go public, David Guyer, CEO for Ophthotech, begins this panel discussion with some of the more trying aspects of going public. Continuing to lead this distinguished panel through a IPO focused conversation, David stresses the importance of timing and perseverance throughout the planning and on…

Read More

More Value to Ophthalmic Innovators Working with Strategic Investors

Evan Norton of Abbott Ventures sees a trend in which corporate investors are moving up their game to an earlier development stage, which could result in more funding opportunities for innovators. “As a strategic investor, we don’t invest in things unless we see a path for them to be acquired by Abbott. We do, however,…

Read More

Funding Ophthalmic Innovation

Angela MacFarlane, President & CEO for ForSight Labs and Emmett Cunningham, Partner for Clarus Ventures co-moderate a segment on funding opportunities for innovative products and procedures in the Ophthalmic space, at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Lending their expert insights on the funding process are panelists Calvin W. Roberts, MD,…

Read More